LongView Wealth Management Reduces Stake in Johnson & Johnson, Stock Trading Up 0.2%

Are you interested in learning more about Johnson & Johnson and its recent financial activities? LongView Wealth Management recently cut its stake in Johnson & Johnson by 2.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,708 shares of the company’s stock, making it the 26th largest holding in their investment portfolio.

Other institutional investors have also made moves with Johnson & Johnson, with some buying new positions and others boosting their holdings. Johnson & Johnson’s stock is currently trading up 0.2%, with a market cap of $351.76 billion. The company recently reported quarterly earnings that beat expectations, with a return on equity of 36.70% and a net margin of 45.26%.

Additionally, Johnson & Johnson recently increased its dividend, providing stockholders with a dividend yield of 3.39%. Analysts have weighed in on the stock, with a mix of neutral and overweight ratings. The company’s profile includes a range of products in the healthcare field, sold worldwide through various channels.

If you want to stay updated on Johnson & Johnson and other companies, visit HoldingsChannel.com for the latest filings and insider trades. Don’t miss out on important news and ratings – sign up for MarketBeat.com’s free daily email newsletter to receive a concise summary of the latest updates. Stay informed and make informed investment decisions.